Liraglutide in United Kingdom: Our Bureau, Bengaluru Friday, February 28, 2025, 15:30 Hrs [IST] Biocon Limited, an innovation-led global ...
Canada Objective To determine whether the use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with an increased risk of suicidal ideation, self-harm, and suicide among patients with ...
15h
HealthDay on MSNGLP-1 Receptor Agonist Use Not Linked to Increased Suicide RiskGlucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with ...
A product development expert explains how the swift rise of these anti-obesity medications is fueling new food trends.
Taiwan: A recent cohort study has highlighted the potential benefits of combining glucagon-like peptide-1 receptor agonists ...
1d
News Medical on MSNNew study confirms GLP-1 medications are safe for mental health in diabetesResearchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...
Consumers taking GLP-1 drugs like Ozempic will need to adapt their shopping habits and diets, opening opportunities for food ...
This cohort study found no significant association between the preoperative use of glucagon-like peptide-1 receptor agonists (GLP-1 ...
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a modestly lower risk for depression compared with dipeptidyl peptidase-4 ...
While one study found lower rates of preterm birth alongside higher rates of hypertensive disorders, another found fewer ...
Outsourcing Facilities Association and North American Custom Laboratories allege the FDA removed semaglutide from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results